Keywords
Tics
Tourette Syndrome
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: Understand the main advances in the treatment of Tourette Syndrome (TS), encompassing pharmacological and non-pharmacological therapies, in the last 5 years. Methods: This is an integrative review, carried out based on searches in databases Publisher Medline (PubMed), Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS), Scientific Electronic Library Online (SCIELO) e Medical Literature Analysis and Retrievel System Online (MEDLINE), from 2018 to 2023, using descriptors “Tourette Syndrome ” and “treatment” and their translations into English, using the boolean operator AND. Results: 31 articles were selected to represent the final sample and compose the review, as they met the inclusion and exclusion criteria, in which pharmacotherapy, deep brain stimulation and behavioral therapy proved to be protagonists in the treatment of the syndrome. Final considerations: It was found that the drugs sodium valproate, tiapride and priavanserin and deep brain stimulation can be used to reduce motor symptoms, and that behavioral therapy is an effective and necessary tool to reduce the severity and control of tics.
References
AMERICAN PSYCHIATRIC ASSOCIATION. Manual diagnóstico e estatístico de transtornos mentais: DSM-5. Porto Alegre: Artmed, 2014; 948.
ANDRÉN P, et al. Therapist-Supported Internet-Delivered Exposure and Response Prevention for Children and Adolescents with Tourette Syndrome: A Randomized Clinical Trial. JAMA Network Open, 2022; 5-8.
BADENOCH J e CAVANNA AE. Pharmacotherapy for tics in adult patients with Tourette syndrome and other tic disorders. Neurological Sciences, 2020; 41: 1923-1926.
BALDERMANN JC, et al. Thalamic deep brain stimulation for Tourette Syndrome: A naturalistic trial with brief randomized, double-blinded sham-controlled periods. Brain Stimulation, 2021; 14: 1059-1067.
BEHLER N, et al. Cathodal tDCS Over Motor Cortex Does Not Improve Tourette Syndrome: Lessons Learned from a Case Series. Front Behav Neurosci, 2018; 12: 194.
BILLNITZER A, et al. Pilot Study to Evaluate Pimavanserin for the Treatment of Motor and Behavioral Symptoms of Tourette Syndrome. Movement Disorders Clinical Practice, 2021; 8: 694-700.
BOTELHO LLR, et al. O método da revisão integrativa nos estudos organizacionais. Gestão e Sociedade, 2011; 5(11): 121-136.
CHEN J, et al. A Chinese herbal formulation, Xiao-Er-An-Shen decoction, attenuates tourettesyndrome, possibly by reversing abnormal changes in neurotransmitter levels and enhancing antioxidant status in mouse brain. Frontiers in pharmacology, 2019; 10: 812.
DONG C, et al. Utilizing network pharmacology to explore the underlying mechanism of Qiangzhidecoction in treating Tourette’s syndrome. Annals of Palliative Medicine, 2020; 9: 6.
DYKE K, et al. Effects of single-session cathodal transcranial direct current stimulation on tic symptoms in Tourette’s syndrome. Experimental brain research, 2019; 237: 2853-2863.
ESSOE JKY, et al. Homework adherence predicts therapeutic improvement from behavior therapy in Tourette's disorder. Behaviour Research and Therapy, 2021; 140: 103- 844.
FARHAT L, et al. Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children, adolescents, and young adults with Tourette's syndrome: a systematic review and network meta-analysis. Lancet Child Adolesc Health, 2023; 7: 112-126.
FEKETE S, et al. Correction to: Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride. European journal of clinical pharmacology, 2021; 77: 8.
GARCIA-ACERO M, ESPINOSA E. Familial Tourette Syndrome: Case Re- port And Review Of Literature. Rev Ecuat Neurol, 2018; 27(2): 87-91.
GILBERT DL, et al. Ecopipam for Tourette Syndrome: A Randomized Trial. American Academy of Pediatrics, 2023; 151(2): 2022059574.
GORBERG V, et al. Different responses of repetitive behaviours in juvenile and young adult mice to Δ9-tetrahydrocannabinol and cannabidiol may affect decision making for Tourette syndrome. Br J Pharmacol, 2021; 178: 614-625.
HUANG C, et al. Effects of Yi-Gan-san on the psychiatric behavior of children and adolescents with Tourette's Syndrome: A randomized, double-blind, controlled preliminary study. Journal of Ethnopharmacology, 2022; 290: 115098.
JAFARI F, et al. Systematic Review and Meta-Analysis of Tourette Syndrome Prevalence; 1986 to 2022. Pediatr Neurol, 2022; 137: 6-16.
JO HJ, et al. Global network modulation during thalamic stimulation for Tourette syndrome. NeuroImage: Clinical, 2018; 18: 502-509.
JOHNSON KA, et al. Basal Ganglia Pathways Associated With Therapeutic Pallidal Deep Brain Stimulation for Tourette Syndrome. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2021; 6: 961-972.
JOHNSON KA, et al. Image-based analysis and long-term clinical outcomes of deep brain stimulation for Tourette syndrome: a multisite study. Journal of Neurology, Neurosurgery & Psychiatry, 2019; 90(10): 1078-1090.
KAHL CK, et al. Bilateral transcranial magnetic stimulation of the supplementary motor area in children with Tourette syndrome. Dev Med Child Neurol, 2021; 66(7): 808-815.
KWON OS, et al. Effects of orthopedic treatment using temporomandibular joint balancing appliance (TBA) at improving the symptoms of tic/Tourette syndrome: case report. Integr Med Res, 2018; 7(4): 381-386.
LI Y, et al. Protocol of a randomized controlled trial to investigate the efficacy and neural correlates of mindfulness-based habit reversal training in children with Tourette syndrome. Frontiers in Psychiatry, 2022; 13.
LI Y, et al. Stereotactic radiofrequency thermocoagulation application in the anterior limbs of patients’ internal capsules in treating intractable tic disorders. International Journal of Hyperthermia, 2020; 37(1): 332-337.
LOUREIRO NIV, et al. Tourette: por dentro da síndrome. Archives of Clinical Psychiatry, 2005; 32(4): 218-230.
MARTINO D, et al. The 5 pillars in Tourette syndrome deep brain stimulation patient selection: present and future. Neurology, 2021; 96(14): 664-676.
MCGUIRE JF, et al. Effect of Behavior Therapy for Tourette’s Disorder on Psychiatric Symptoms and Functioning in Adults. Psychological Medicine, 2020; 50: 2046-2056.
MCGUIRE JF, et al. Optimizing behavior therapy for youth with Tourette’s disorder. Neuropsychopharmacology, 2020; 45: 2114-2119.
MOLINA R, et al. Report of a patient undergoing chronic responsive deep brain stimulation for Tourette syndrome: proof of concept. Journal of Neurosurgery, 2018; 129: 308-314.
MULLER-VAHL KR, et al. Endocannabinoid modulation using monoacylglycerol lipase inhibition in Tourette syndrome: a phase 1 randomized, placebo-controlled study. Pharma-copsychiatry, 2022; 55(3): 148-156.
MULLER-VAHL KR, et al. European clinical guidelines for Tourette syndrome and other tic disorders: summary statement. Eur Child Adolesc Psychiatry, 2022; 31: 377-382.
PRINGSHEIM T, et al. Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology, 2019; 92: 896-906.
RAMIREZ MD, et al. Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome: The International Tourette Syndrome Deep Brain Stimulation Public Database and Registry. JAMA neurology, 2018; 75(3): 353-359.
RIZZO R, et al. A Randomized Controlled Trial Comparing Behavioral, Educational, and Pharmacological Treatments in Youths with Chronic Tic Disorder or Tourette Syndrome. Frontiers in Psychiatry, 2018; 9: 100.
RODRIGO L, et al. Efficacy of a Gluten-Free Diet in the Gilles de la Tourette Syndrome: A Pilot Study. Nutrients, 2018; 10(5): 573.
TAO D, et al. Randomized controlled clinical trial comparing the efficacy and tolerability of aripiprazole and sodium valproate in the treatment of Tourette syndrome. Annals of General Psychiatry, 2019; 18(1): 1-9.
TEIXEIRA L, et al. Síndrome de La Tourette: Revisão de Literatura. Arquivos Internacionais de Otorrinolaringologia, 2011; 15: 492-500.
URRUTIA S e HERNANDEZ CH. Descripción de uma cohorte pediátrica com síndrome de Gilles de la Tourette. Andes Pediatrica, 2021; 92(6): 838.
YU W, et al. Jian-Pi-Zhi-Dong-Decoction regulates the expression of glutamate transporters to attenuate glutamate excitotoxicity and exerts anti-tics effects in Tourette syndrome model rats. Neuropsychiatr Dis Treat, 2018; 14: 3381–3392.